PaxMedica, Inc.
News
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
Globe Newswire TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the Company or PaxMedica ) (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for...\n more…
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
Globe Newswire TARRYTOWN, New York, May 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (OTC:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, provided a...\n more…
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast
Globe Newswire LOS ANGELES, April 26, 2024 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...\n more…
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
Globe Newswire TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN PaxMedica Inc. (Nasdaq: PXMD) (the Company ), a leading biopharmaceutical company dedicated to advancing treatments for...\n more…
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
Globe Newswire Emergent shortages of the drug used to treat the most severe form of African sleeping sickness creates immediate need for direct access to the global drug market for affected nationsAs previously...\n more…